These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2546702

  • 1. Mechanisms other than polyclonal B cell activation possibly involved in Epstein-Barr virus-induced autoimmunity.
    Garzelli C, Pacciardi A, Basolo F, Falcone G.
    Clin Exp Immunol; 1989 Jun; 76(3):412-6. PubMed ID: 2546702
    [Abstract] [Full Text] [Related]

  • 2. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G, Magrath I, Koski I, Dooley N, Blaese M.
    N Engl J Med; 1979 Nov 22; 301(21):1133-7. PubMed ID: 226884
    [Abstract] [Full Text] [Related]

  • 3. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J.
    Scand J Infect Dis Suppl; 1996 Nov 22; 100():72-82. PubMed ID: 8860357
    [Abstract] [Full Text] [Related]

  • 4. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Nov 22; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 5. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
    Wang F, Blaese RM, Zoon KC, Tosato G.
    J Clin Invest; 1987 Jan 22; 79(1):7-14. PubMed ID: 3025263
    [Abstract] [Full Text] [Related]

  • 6. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G, Rickinson AB.
    Immunology; 1987 Dec 22; 62(4):647-54. PubMed ID: 2828228
    [Abstract] [Full Text] [Related]

  • 7. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G, Straus S, Henle W, Pike SE, Blaese RM.
    J Immunol; 1985 May 22; 134(5):3082-8. PubMed ID: 2984282
    [Abstract] [Full Text] [Related]

  • 8. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G, Magrath IT, Blaese RM.
    J Immunol; 1982 Feb 22; 128(2):575-9. PubMed ID: 6274959
    [Abstract] [Full Text] [Related]

  • 9. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 22; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 10. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E.
    Cancer Res; 1981 Nov 22; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [Abstract] [Full Text] [Related]

  • 11. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb 22; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 12. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R.
    Nat Rev Immunol; 2003 Oct 22; 3(10):801-12. PubMed ID: 14523386
    [Abstract] [Full Text] [Related]

  • 13. Detection of an idiotope on a human monoclonal autoantibody by monoclonal anti-idiotypic antibody and its relationship to Epstein-Barr virus-induced autoimmunity.
    Garzelli C, Incaprera M, Bazzichi A, Falcone G.
    Autoimmunity; 1992 Oct 22; 11(3):171-7. PubMed ID: 1315162
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
    Kurth J, Hansmann ML, Rajewsky K, Küppers R.
    Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4730-5. PubMed ID: 12665622
    [Abstract] [Full Text] [Related]

  • 15. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis.
    Buisson M, Berthelot JM, Le Goff P, Chastel C, Lamour A, Seigneurin JM, Youinou P.
    J Autoimmun; 1994 Aug 15; 7(4):485-95. PubMed ID: 7980850
    [Abstract] [Full Text] [Related]

  • 16. A human monoclonal autoantibody isolated from a patient with infectious mononucleosis reactive with both self antigens and Epstein-Barr virus nuclear antigen (EBNA).
    Garzelli C, Pacciardi A, Carmignani M, Conaldi G, Basolo F, Falcone G.
    Immunol Lett; 1989 Sep 15; 22(3):211-6. PubMed ID: 2478456
    [Abstract] [Full Text] [Related]

  • 17. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
    Rhodes G, Carson DA, Valbracht J, Houghten R, Vaughan JH.
    J Immunol; 1985 Jan 15; 134(1):211-6. PubMed ID: 2981091
    [Abstract] [Full Text] [Related]

  • 18. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA.
    J Immunol; 1980 Feb 15; 124(2):745-51. PubMed ID: 6243331
    [Abstract] [Full Text] [Related]

  • 19. Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis.
    Hutt LM, Huang YT, Dascomb HE, Pagano JS.
    J Immunol; 1975 Jul 15; 115(1):243-8. PubMed ID: 168255
    [Abstract] [Full Text] [Related]

  • 20. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF, Goldmacher VS, Lambert JM, Schlossman SF.
    J Immunol; 1986 Aug 15; 137(4):1387-91. PubMed ID: 3016095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.